-
Mashup Score: 0Mobile App - ADA Meeting News - 9 day(s) ago
MOBILE APP Developed specifically for the ADA’s 85th Scientific Sessions, the coordinating mobile event app and Online Planner are your go-to meeting resources with details on educational session information, news […]
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 3Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes | American Diabetes Association - 9 day(s) ago
A recent study found that oral semaglutide offers meaningful cardiovascular benefits for people with type 2 diabetes, lowering risk by 14%.
Source: diabetes.orgCategories: General Medicine News, EndocrinologyTweet-
PRESS RELEASE: Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes Details: https://t.co/KuLIuYsJEh #ADASciSessions https://t.co/QTsuXL8J4m
-
-
Mashup Score: 0Dr. Felicia Hill-Briggs Health Equity Trailblazers in Diabetes Award debuts - ADA Meeting News - 9 day(s) ago
A leading scholar in epidemiology and health equity, Tiffany L. Gary-Webb, PhD, MHS, will receive the inaugural Dr. Felicia Hill-Briggs Health Equity Trailblazers in Diabetes Award.
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet-
Sunday at #ADASciSessions: @DrTGaryWebb will receive the inaugural Dr. Felicia Hill-Briggs Health Equity Trailblazers in Diabetes Award. 🏆 🔗 Learn more: https://t.co/Luhz0bAFAw https://t.co/qivXwEYSOT
-
-
Mashup Score: 1Symposium will explore next gen agents for type 2 diabetes and obesity - ADA Meeting News - 9 day(s) ago
Panelists, including Dimitris Papamargaritis, MCRP, PhD, will discuss emerging therapies targeting the hormones glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), glucagon, and amylin.
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet-
What does the treatment landscape look like for type 2 diabetes and obesity? An #ADASciSessions symposium will spotlight emerging hormone-targeting therapies. 🔗 Preview the session here: https://t.co/4hBstjvAXM https://t.co/aclrz9YZ7D
-
-
Mashup Score: 1
Today, a new study demonstrates inhaled insulin as a safe and effective replacement for rapid-acting meal insulin in children with type 1 diabetes.
Source: diabetes.orgCategories: General Medicine News, EndocrinologyTweet-
PRESS RELEASE: Inhaled Insulin Shown as a Safe and Effective Replacement for Standard-of-Care in Children with Type 1 Diabetes Details: https://t.co/lUpvwa8DW8 #ADASciSessions https://t.co/OTY9Q5XCcJ
-
-
Mashup Score: 3Once-Weekly Insulin Efsitora Achieves Comparable A1C Reduction to Daily Insulin Therapy | American Diabetes Association - 9 day(s) ago
Today, findings from the QWINT-1 study found once-weekly insulin efsitora alfa (efsitora) lowered blood glucose (blood sugar) levels as effectively as daily basal insulin in insulin-naïve type 2 diabetes.
Source: diabetes.orgCategories: General Medicine News, EndocrinologyTweet-
PRESS RELEASE: Once-Weekly Insulin Efsitora Achieves Comparable A1C Reduction to Daily Insulin Therapy Details: https://t.co/GGK58BL5SE #ADASciSessions https://t.co/zzIW0R9YNP
-
-
Mashup Score: 3Session to explore GLP-1, GIP RAs in mental disorders, addiction, and more - ADA Meeting News - 9 day(s) ago
Roger S. McIntyre, MD, FRCPC, and other investigators will outline unanticipated effects of using incretin receptor agonists outside of the clinical impact on weight loss and metabolic disorders.
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet-
#ADASciSessions Preview: @rogersmcintyre and other experts will highlight several unexpected effects of using incretin receptor agonists beyond weight loss and metabolic disorders. 🔗 Read more: https://t.co/HyZTu2Yj1l https://t.co/SqfZJpeRjt
-
-
Mashup Score: 383rd Scientific Sessions | American Diabetes Association - 9 day(s) ago
There are companies that are claiming to offer registration services for ADA’s Scientific Sessions, which are not affiliated with ADA and do not offer any servi ces on our behalf. Registration should only be accessed from the ADA website. If you do not see this logo on the website then they are not our official provider! If you were unable to attend the American Diabetes Association 83rd Scientific Sessions, it’s not too late to access over 800 presentations highlighting the most exciting science in
Source: professional.diabetes.orgCategories: General Medicine News, EndocrinologyTweet-
The 84th Scientific Sessions is seeking high-quality, innovative session proposals to enhance next year's event. This is your chance to contribute to the scientific program and showcase the latest advancements. Submit your proposals by August 14, 2023! https://t.co/yIQNrh28L6 https://t.co/sWI4Igt5eI
-
-
Mashup Score: 42024 Recognized Abstracts | American Diabetes Association - 9 day(s) ago
LYNN ANG, YI YUAN HUANG, CATHERINE MARTIN, KARA R. MIZOKAMI-STOUT, YU KUEI LIN, ALEXI VASBINDER, MOUSUMI BANERJEE, SALIM HAYEK, EVA L. FELDMAN, RODICA BUSUI, Ann Arbor, MI ADAM SEAL, STEVEN K. MALIN, ANDREW SCHAFFNER, MICHAEL R. HUBBARD, SARAH K. KEADLE, HANNAH BRUNNER-GAYDOS, ALIA A. ORTIZ, JANE E. NAKAMURA, CLARA MCMAHON, RACHEL BARNETT, ANITA H. KELLEHER, KELLY A. BENNION, SUZANNE PHELAN, TODD HAGOBIAN, San Luis Obispo, CA, New Brunswick, NJ, Gilbert, AZ, San, CA, Seattle, WA, San Francisco, CA JURAJ
Source: professional.diabetes.orgCategories: General Medicine News, EndocrinologyTweet-
The Health Disparities Committee’s Top 10 Recommended Abstracts recognizes abstracts that have been accepted to the #ADASciSessions. These abstracts focus on health care disparities/inequities in diabetes outcomes. For more information, visit https://t.co/bcCnMJKh0g. https://t.co/CIUuBFuJK9
-
-
Mashup Score: 3CagriSema Demonstrates Significant Weight Loss in Adults with Obesity | American Diabetes Association - 10 day(s) ago
Findings from two studies highlight the potential for CagriSema, a dual agonist that targets both glucose regulation and appetite control, to improve weight loss in patients with and without type 2 diabetes who have overweight or obesity.
Source: diabetes.orgCategories: General Medicine News, EndocrinologyTweet-
PRESS RELEASE: CagriSema Demonstrates Significant Weight Loss in Adults with Obesity Details: https://t.co/Z0gFk09WxO #ADASciSessions https://t.co/I0mUasgbpE
-
📱 tomorrow is the big day! Start your day right! Download the ADA app for all session schedules and updates. #ADASciSessions https://t.co/EzIDiSWK3C https://t.co/6KsgrAro6x